Biotech

All Articles

Analysts examine Avidity's DMD win, uncovering subtleties in information

.Avidity Biosciences impressed capitalists along with stage 1/2 data in Duchenne muscular dystrophy ...

Actinogen's cortisol blocker neglects phase 2 anxiety research

.Actinogen Medical's cortisol blocker has missed out on the main endpoint of a period 2 study in anx...

Bivictrix makes a decision going personal only method to take ADC right into facility

.Antibody-drug conjugates (ADCs) have actually gone to the center of several a billion-dollar biobuc...

TPG tops up funds to $580M for expenditures all over life sciences

.Resource supervisor TPG, which has sustained biotechs including Sionna Therapies and Santa Ana Bio,...

Merck ceases stage 3 TIGIT trial in bronchi cancer cells for impossibility

.Merck &amp Co.'s TIGIT system has actually experienced one more drawback. Months after shuttering a...

After a tough year, Exscientia folds in to Recursion

.After a year defined through pipe hairstyles, the variation of its CEO and layoffs, Exscientia will...

Cullinan, after $25M bargain, return bispecific to Harbour

.Cullinan Rehab was blown away good enough along with Harbour BioMed's bispecific invulnerable activ...

A nearer check out Fierce Biotech's Intense 15

.In this week's incident of "The Best Pipe," our team are actually diving right into Brutal Biotech'...

Lilly faces period 2 failure of tau-targeting med

.The confetti is actually still soaring coming from Eli Lilly's gathering celebrating the commendati...

Biogen CMO Maha Radhakrishnan joins Sofinnova-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our summary of notable management hirings, firings as wel...